We recently published a list of Jim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings Season. In this article, we are going to take a look at where Resmed Inc. (NYSE:RMD) stands against other stocks that Jim Cramer is discussing ahead of Q1 earnings season.

Jim Cramer in a latest program on CNBC talked about the winning sectors so far this year and said the trends show a “strange” pattern. Cramer specifically mentioned the oil and gas sector which he believed would underperform given President Donald Trump’s plan to keep energy prices lower.

“I thought this group would be down given that the president wants to expand drill and we have a slower economy, but the stocks aren’t expensive and demand for natural gas very strong,” Cramer said.

Cramer also talked about healthcare and other key sectors that performed well. He believes these patterns show that investors are turning to sectors that perform well during recessions. However, Cramer thinks the state of the economy is better than feared.

“The seven stocks that make up the S&P are too big to dismiss. You need at least some of them to put together a really positive tape. But the bottom line, it’s terrific to see such a broad mixture of stocks winning here, from ones that can run in a recession to ones that can rally hard in a robust economy. What it tells me is that the market may be far healthier than we think, and this backdrop simply isn’t as bad as many would have you believe.”

READ ALSO: 7 Best Stocks to Buy For Long-Term and 8 Cheap Jim Cramer Stocks to Invest In

For this article, we picked 10 stocks Jim Cramer recently talked about during his programs on CNBC. With each company, we have mentioned the number of hedge fund investors. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

A healthcare professional in a protective mask and headgear adjusting a ventilation device.

Resmed Inc. (NYSE:RMD)

Number of Hedge Fund Investors: 34

Jim Cramer said in a latest program on CNBC that he likes Resmed Inc. (NYSE:RMD), which makes treatments for sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions.

“Mick Farrell came on the show and told me that my reservations about the recommended stock, which is about GLP-1, were misplaced and the company’s doing quite well. I’m with Mick, he’s never steered me wrong. I like the stock.”

Story Continues

Fidelity Growth Strategies Fund stated the following regarding ResMed Inc. (NYSE:RMD) in its Q3 2024 investor letter:

“The fund’s bigger-than-benchmark position in medical equipment designer ResMed Inc. (NYSE:RMD) (+15%) was the next-largest contributor. ResMed’s primary focus is sleep technology – it provides cloud-connected devices for the treatment of respiratory conditions like sleep apnea and chronic obstructive pulmonary disease. The stock declined sharply in the second half of 2023, in the wake of market speculation that the rise of weight-loss drugs would negatively impact sales and usage of ResMed’s devices. But it has risen steadily since then, helped this quarter by an August earnings report that showed steady sales and improving profitability. That said, the stock was no longer in the portfolio at quarter end.”

Overall, RMD ranks 9th on our list of stocks that Jim Cramer is discussing ahead of Q1 earnings season. While we acknowledge the potential of RMD, our conviction lies in the belief that under the radar AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than RMD but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.

View Comments